Low-dose T3 replacement restores depressed cardiac T3 levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 302-312

  Weltman, Nathan Y ^a   Ojamaa, Kaie ^b   Schlenker, Evelyn H ^a   Chen, Yue Feng ^d   Zucchi, Riccardo ^c   Saba, Alessandro ^c   Colligiani, Daria ^c   Rajagopalan, Viswanathan ^d   Pol, Christine J ^d   Gerdes, A Martin ^d  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b Center for Heart and Lung Research North Shore LIJ Health System The Feinstein Institute for Medical Research ^*  (United States)

^c UNIVERSITY OF PISA   (Italy)

^d NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; LIOTHYRONINE; MYOSIN HEAVY CHAIN; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THYROID HORMONE; THYROID HORMONE TRANSPORTER; THYROXINE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLAR RESISTANCE VESSEL DENSITY; ARTICLE; BLOOD VESSEL PARAMETERS; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENE; GENE EXPRESSION; HEART DISEASE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE SIZE; HORMONE SUBSTITUTION; HYPOTHYROIDISM; LOW DRUG DOSE; MHC GENE; MICROVASCULATURE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; THYROID HORMONE BLOOD LEVEL; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GENETICS; HEART MUSCLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HEMODYNAMICS; HORMONE REPLACEMENT THERAPY; MYOCARDIUM; RATS, SPRAGUE-DAWLEY; THYROID HORMONES; VENTRICULAR REMODELING;

EID: 84905166435     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00040     Document Type: Article

References (61)

1. Kannel W. (1985) Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am. Heart J. 110:1110-7.
2. Fuller J, Shipley M, Rose G, Jarrett R, Keen H. (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br. Med. J. 287:867-70.
3. Falcao-Pires I, Leite-Moreira A. (2011) Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail. Rev. 17:325-44.
4. Yoon Y, et al. (2005) Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy-Restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation. 111:2073-85.
5. Miki T, Yuda S, Kouzu H, Miura T. (2013) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev. 18:149-66.
6. Battiprolu PK, Lopez-Crisosto C, Wang ZV, Nemchenko A, Lavandero S, Hill JA. (2013) Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci. 92:609-15.
7. Klein I, Ojamaa K. (2001) Mechanisms of disease: Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344:501-9.
8. Kahaly G, Dillmann W. (2005) Thyroid hormone action in the heart. Endocr. Rev. 26:704-28.
9. Gerdes A, Iervasi G. (2010) Thyroid replacement therapy and heart failure. Circulation. 122:385-93.
10. Rodondi N, et al. (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 304:1365-74.
11. Tseng F, et al. (2012) Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J. Am. Coll. Cardiol. 60:730-7.
12. McQuade C, Skugor M, Brennan D, Hoar B, Stevenson C, Hoogwerf B. (2011) Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a preCIS database study. Thyroid. 21:837-43.
13. Tang Y, Kuzman J, Said S, Anderson B, Wang X, Gerdes A. (2005) Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 112:3122-30.
14. Chen J, et al. (2012) Thyroid hormone induces sprouting angiogenesis in adult heart of hypothyroid mice through the PDGF-Akt pathway. J. Cell. Mol. Med. 16:2726-35.
15. Pol C, et al. (2011) Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology. 152:669-79.
16. Wassen F, et al. (2002) Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology. 143:2812-5.
17. Olivares E, et al. (2007) Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats-a time course study. Endocrinology. 148:4786-92.
18. Simonides W, et al. (2008) Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J. Clin. Invest. 118:975-83.
19. Gray R, Seth D, Herd R, Brown N, Clark B. (1980) Prevalence of subclinical thyroidal failure in insulin dependent diabetes. J. Clin. Endocrinol. Metab. 50:1034-7.
20. Pittman C, Suda A, Chambers J, Ray G. (1979) Impaired 3,5,3 T3 production in diabetic patients. Metabolism. 28:333-8.
21. Duntas L, J. O, Brabant G. (2011) The interface between thyroid and diabetes mellitus. Clin. Endocrinol. 75:1-9.
22. Chen H, et al. (2007) Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabetic Med. 24:1336-44.
23. Sayen M, Rohrer D, Dillmann W. (1992) Thyroid hormone response of slow and fast sarcoplasmic reticulum Ca2+ ATPase mRNA in striated muscle. Mol. Cell. Endocrinol. 87:87-93.
24. Haddad F, Masatsugu M, Bodell P, Qin A, McCue S, Baldwin K. (1997) Role of thyroid hormone and insulin in control of cardiac isomyosin expression. J. Mol. Cell. Cardiol. 29:559-69.
25. Baycan S, et al. (2007) Coronary flow reserve is impaired in subclinical hypothyroidism. Clin. Cardiol. 30:562-6.
26. Taddei S, et al. (2003) Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88:3731-7.
27. Takiguchi Y, Satoh N, Hashimoto H, Nakashima M. (1989) Reversal effect of thyroxine on altered vascular reactivity in diabetic rats. J. Cardiovasc. Pharmacol. 13:520-4.
28. Akella A, Ding X, Cheng R, Gulati J. (1995) Diminished Ca2+ sensitivity of skinned cardiac muscle contractility coincident with troponin Tband shifts in the diabetic rat. Circ. Res. 76:600-6.
29. Trost S, Belke D, Bluhm W, Meyer M, Swanson E, Dillmann W. (2002) Overexpression of the sarcoplasmic reticulum Ca2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes. 51:1166-71.
30. Shenoy R, Klein I, Ojamaa K. (2001) Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am. J. Physiol. Heart Circ. Physiol. 281:H1690-6.
31. Ojamaa K, Kenessey A, Klein I. (2000) Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology. 141:2139-44.
32. Davidoff A, Rodgers R. (1990) Insulin, thyroid hormone, and heart function of diabetic spontaneously hypertensive rat. Hypertension. 15:633-42.
33. Institute of Laboratory Animal Resources (U.S.), Committee on Care and Use of Laboratory Animals. (1985) Guide for the Care and Use of Laboratory Animals. Rev. 1985. Bethesda (MD): NIH. 83 pp. (NIH publication; no. 85-23).
34. Savinova O, et al. (2011) Thyroid hormone promotes remodeling of coronary resistance vessels. Plos One. 6:e25054.
35. Weltman N, et al. (2013) Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats. Endocrinology. 154:2542-52.
36. Freitas B, et al. (2010) Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J. Clin. Invest. 120:2206-17.
37. Medina M, et al. (2011) The thyroid hormoneinactivating type III deiodinase is expressed in mouse and human beta-cells and its targeted inactivation impairs insulin secretion. Endocrinology. 152:3717-27.
38. Shukla PK, Sittig LJ, Ullmann TM, Redei EE. (2011) Candidate placental biomarkers for intrauterine alcohol exposure. Alcohol. Clin. Exp. Res. 35:559-65.
39. Chen H, Brahmbhatt S, Gupta A, Sharma AC. (2005) Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction. Cardiovasc. Diabetol. 4:3.
40. Kinugawa K, et al. (2001) Signaling pathways responsible for fetal gene induction in the failing human heart-Evidence for altered thyroid hormone receptor gene expression. Circulation. 103:1089-94.
41. Bianco AC, Larsen PR. (2005) Cellular and structural biology of the deiodinases. Thyroid. 15:777-786.
42. Liu Y, Redetzke R, Said S, Pottala J, de Escobar G, Gerdes A. (2008) Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am. J. Physiol. Heart Circ. Physiol. 294:H2137-43.
43. Cappelli C, et al. (2009) TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients Differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 32:1589-90.
44. Pol C, Muller A, Simonides W. (2010) Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem? Heart Fail. Rev. 15:133-42.
45. Mebis L, et al. (2009) Expression of thyroid hormone transporters during critical illness. Eur. J. Endocrinol. 161:243-250.
46. Friesema ECH, Jansen J, Jachtenberg JW, Visser WE, Kester MHA, Visser TJ. (2008) Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol. Endocrinol. 22:1357-69.
47. Friesema E, Ganguly S, Abdalla A, Fox J, Halestrap A, Visser T. (2003) Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J. Biol. Chem. 278:40128-35.
48. Visser W, Friesema E, Visser T. (2011) Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 25:1-14.
49. Roy S, Mishra S, Ghosh G, Bandyopadhyay A. (2007) Thyroid hormone induces myocardial matrix degradation by activating matrix metalloproteinase-1. Matrix Biol. 26:269-79.
50. Yao J, Eghbali M. (1992) Decreased collagen gene expression and absence of fibrosis in thyroid hormone induced myocardial hypertrophy-response of cardiac fibroblasts to thyroid hormone in vitro. Circ. Res. 71:831-9.
51. van Heerebeek L, et al. (2008) Diastolic stiffness of the failing diabetic heart-Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 117:43-51.
52. Raev D. (1994) Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care. 17:633-9.
53. Oshiro Y, Shimabukuro M, Takasu N, Asahi T, Komiya I, Yoshida H. (2001) Triiodothyronine concomitantly inhibits calcium overload and postischemic myocardial stunning in diabetic rats. Life Sciences. 69:1907-18.
54. Luidens M, Mousa S, Davis F, Lin H, Davis P. (2010) Thyroid hormone and angiogenesis. Vasc. Pharmacol. 52:142-5.
55. McAllister R, Albarracin I, Price E, Smith T, Turk J, Wyatt K. (2005) Thyroid status and nitric oxide in rat arterial vessels. J. Endocrinol. 185:111-9.
56. Khalife W, et al. (2005) Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol289:H2409-15.
57. Makino A, Suarez J, Wang H, Belke D, Scott B, Dillmann W. (2009) Thyroid hormone receptorbeta is associated with coronary angiogenesis during pathological cardiac hypertrophy. Endocrinology. 150:2008-15.
58. Kubis N, Richer C, Domergue V, Giudicelli J, Levy B. (2002) Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS-/-). J. Hypertens. 20:1581-7.
59. Carmeliet P, et al. (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188). Nat. Med. 5:495-502.
60. Kitahara T, et al. (2010) Serum midkine as a predictor of cardiac events in patients with chronic heart failure. J. Card. Fail. 16:308-13.
61. Liu Y, Wang D, Redetzke R, Sherer BA, Gerdes AM. (2009) Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function. Am. J. Physiol. Heart Circ. Physiol. 296:H1551-7.